A Push for Pediatric Biologics Skips Over Why Clinicians Hesitate

A conference Q&A urging dermatology clinicians to embrace immunologic pathways and push harder for pediatric biologics glosses over how narrow FDA-approved options for children actually are, and how much the message doubles as promotion for the sponsoring conference.